Robert M Califf1, Stephen Ostroff2. 1. Robert M. Califf is Deputy Commissioner for Medical Products and Tobacco at the U.S. Food and Drug Administration (FDA), U.S. Department of Health and Human Services, Silver Spring, MD 20993, USA.Stephen Ostroff is Acting Commissioner at FDA, U.S. Department of Health and Human Services, Silver Spring, MD 20993, USA. robert.califf@fda.hhs.gov. 2. Robert M. Califf is Deputy Commissioner for Medical Products and Tobacco at the U.S. Food and Drug Administration (FDA), U.S. Department of Health and Human Services, Silver Spring, MD 20993, USA.Stephen Ostroff is Acting Commissioner at FDA, U.S. Department of Health and Human Services, Silver Spring, MD 20993, USA.
Authors: Andrzej Górski; Ryszard Międzybrodzki; Beata Weber-Dąbrowska; Wojciech Fortuna; Sławomir Letkiewicz; Paweł Rogóż; Ewa Jończyk-Matysiak; Krystyna Dąbrowska; Joanna Majewska; Jan Borysowski Journal: Front Microbiol Date: 2016-09-26 Impact factor: 5.640